Reagent kit "DS-ELISA-ANTI-HCV-SPECTRUM-GM" Enzyme immunoassay system for detecting the spectrum of antibodies of IgG and IgM class to the hepatitis C virus and confirming the results of anti-HCV screening according to TU 9398-095-05941003-2013 Composed of: - immunosorbent; - conjugate (concentrate); - K- - negative control sample; - K+ - positive control sample; - RRB - solution for diluting the conjugate; - BR block solution for working dilution of serums; - PR (concentrate x 25) - flushing solution; - stop reagent; - TMB-Substrate solution, ready for use (when completing the set TMB-substrate solution); or - SB-substrate buffer solution; - TMB-chromogen-3,3', 5,5'-tetramethylbenzidine. - Roszdravnadzor Registration ФСР 2008/03021
Access comprehensive regulatory information for Reagent kit "DS-ELISA-ANTI-HCV-SPECTRUM-GM" Enzyme immunoassay system for detecting the spectrum of antibodies of IgG and IgM class to the hepatitis C virus and confirming the results of anti-HCV screening according to TU 9398-095-05941003-2013 Composed of: - immunosorbent; - conjugate (concentrate); - K- - negative control sample; - K+ - positive control sample; - RRB - solution for diluting the conjugate; - BR block solution for working dilution of serums; - PR (concentrate x 25) - flushing solution; - stop reagent; - TMB-Substrate solution, ready for use (when completing the set TMB-substrate solution); or - SB-substrate buffer solution; - TMB-chromogen-3,3', 5,5'-tetramethylbenzidine. in the Russia medical device market through Pure Global AI's free database. This medical device is registered under Roszdravnadzor registration number ФСР 2008/03021 and manufactured by LLC "NPO "Diagnostic Systems". The device was registered on April 05, 2022.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.

